Explore more publications!

Maine Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maine Business Gazette.

Press releases published on March 20, 2026

Sironax Announces Upcoming Poster Presentation on NAMPT Activation
Excellence in Impaired Driving Enforcement Recognized at Inaugural MADD Canada New Brunswick Police Awards
L’excellence dans la lutte contre la conduite avec capacités affaiblies soulignée lors des prix inauguraux de la police du Nouveau-Brunswick de MADD Canada
Baker Hughes Announces Dates for First-quarter Earnings Release and Webcast 
OMS Energy Technologies (NASDAQ: OMSE) Saudi Arabia Subsidiary Receives US$11 Million Call-Off Order from Saudi Aramco Under Long-Term Supply Agreement
维泰瑞隆宣布即将展示关于NAMPT激活研究的海报
iFAST Global Bank Launches Multi-Currency Business Account with Competitive Interest Rates and Xero Integration for Solicitors, Accountants and Property Managers
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
Global Bio-Based Surfactants Market Valued at $18.8 Billion, Projected to Reach $27.3 Billion by 2030 as ESG Mandates and Consumer Demand Reshape the Chemicals Sector
Free Spins No Deposit Bonus 2026 - Online Casino Real Money No Deposit By My Bookie
Bitcoin Beyond the Halving: Why CoinEx Sees a More Selective, Institutional Crypto Cycle Ahead
iSpring Releases Beginner-Friendly Outdoor Water Safety Guide Featuring Compact Filter Straw for Hikers, Campers, and Everyday Adventurers
Zoomex Launches Twin Stars Cup Trading Competition with Up to $150,000 Prize Pool
Bitget CFD Volume Tops $6 Billion in a Day
Matrixport Rebrands as BIT in Strategic Repositioning
Burn Slim Safeness Issues Arise Do NOT Buy from Third-Party Retail Websites to Avoid Side Effects Risk
BC Poker Bonus 2026: $5 Free No Deposit Poker Bonus for New Crypto Players
The Cost of Bleeding Revealed: Menstruation costs £20,359 a lifetime, sparking calls for Government action
Notice of Full Year Results and Investor Presentation
Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions